» Articles » PMID: 37020120

Proteome Alterations in Human Autopsy Tissues in Relation to Time After Death

Overview
Publisher Springer
Specialty Biology
Date 2023 Apr 5
PMID 37020120
Authors
Affiliations
Soon will be listed here.
Abstract

Protein expression is a primary area of interest for routine histological diagnostics and tissue-based research projects, but the limitations of its post-mortem applicability remain largely unclear. On the other hand, tissue specimens obtained during autopsies can provide unique insight into advanced disease states, especially in cancer research. Therefore, we aimed to identify the maximum post-mortem interval (PMI) which is still suitable for characterizing protein expression patterns, to explore organ-specific differences in protein degradation, and to investigate whether certain proteins follow specific degradation kinetics. Therefore, the proteome of human tissue samples obtained during routine autopsies of deceased patients with accurate PMI (6, 12, 18, 24, 48, 72, 96 h) and without specific diseases that significantly affect tissue preservation, from lungs, kidneys and livers, was analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). For the kidney and liver, significant protein degradation became apparent at 48 h. For the lung, the proteome composition was rather static for up to 48 h and substantial protein degradation was detected only at 72 h suggesting that degradation kinetics appear to be organ specific. More detailed analyses suggested that proteins with similar post-mortem kinetics are not primarily shared in their biological functions. The overrepresentation of protein families with analogous structural motifs in the kidney indicates that structural features may be a common factor in determining similar postmortem stability. Our study demonstrates that a longer post-mortem period may have a significant impact on proteome composition, but sampling within 24 h may be appropriate, as degradation is within acceptable limits even in organs with faster autolysis.

Citing Articles

"Omics" and Postmortem Interval Estimation: A Systematic Review.

Secco L, Palumbi S, Padalino P, Grosso E, Perilli M, Casonato M Int J Mol Sci. 2025; 26(3).

PMID: 39940802 PMC: 11817326. DOI: 10.3390/ijms26031034.


A multi-tissue longitudinal proteomics study to evaluate the suitability of post-mortem samples for pathophysiological research.

Beusch C, Braesch-Andersen K, Felldin U, Sabatier P, Widgren A, Bergquist J Commun Biol. 2025; 8(1):78.

PMID: 39824970 PMC: 11742016. DOI: 10.1038/s42003-025-07515-z.


DNA methylation stability in cardiac tissues kept at different temperatures and time intervals.

Poggiali B, Dupont M, Jacobsen S, Smerup M, Christiansen S, Tfelt-Hansen J Sci Rep. 2024; 14(1):25170.

PMID: 39448773 PMC: 11502879. DOI: 10.1038/s41598-024-76027-3.


Enhancing late postmortem interval prediction: a pilot study integrating proteomics and machine learning to distinguish human bone remains over 15 years.

Garces-Parra C, Saldivia P, Hernandez M, Uribe E, Roman J, Torrejon M Biol Res. 2024; 57(1):75.

PMID: 39444040 PMC: 11515459. DOI: 10.1186/s40659-024-00552-8.


Exploring the Early Molecular Pathogenesis of Osteoarthritis Using Differential Network Analysis of Human Synovial Fluid.

Ryden M, Sjogren A, Onnerfjord P, Turkiewicz A, Tjornstrand J, Englund M Mol Cell Proteomics. 2024; 23(6):100785.

PMID: 38750696 PMC: 11252953. DOI: 10.1016/j.mcpro.2024.100785.


References
1.
Cao L, Huang C, Zhou D, Hu Y, Lih T, Savage S . Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021; 184(19):5031-5052.e26. PMC: 8654574. DOI: 10.1016/j.cell.2021.08.023. View

2.
Wu S, Cooper B, Bu F, Bowman C, Killian J, Serrano J . DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas. JCO Precis Oncol. 2018; 2017. PMC: 5772901. DOI: 10.1200/PO.17.00031. View

3.
Ferreira P, Munoz-Aguirre M, Reverter F, Sa Godinho C, Sousa A, Amadoz A . The effects of death and post-mortem cold ischemia on human tissue transcriptomes. Nat Commun. 2018; 9(1):490. PMC: 5811508. DOI: 10.1038/s41467-017-02772-x. View

4.
Fan J, Khanin R, Sakamoto H, Zhong Y, Michael C, Pena D . Quantification of nucleic acid quality in postmortem tissues from a cancer research autopsy program. Oncotarget. 2016; 7(41):66906-66921. PMC: 5341846. DOI: 10.18632/oncotarget.11836. View

5.
Hooper J . Rapid Autopsy Programs and Research Support: The Pre- and Post-COVID-19 Environments. AJSP Rev Rep. 2021; 26(2):100-107. PMC: 7954201. View